Schroeder et al., 2016 - Google Patents
Graphene Quantum Dots for Theranostics and Bioimaging: KL Schroeder et al.Schroeder et al., 2016
- Document ID
- 290995285232405136
- Author
- Schroeder K
- Goreham R
- Nann T
- Publication year
- Publication venue
- Pharmaceutical research
External Links
Snippet
Since their advent in the early 1990s, nanomaterials hold promise to constitute improved technologies in the biomedical area. In particular, graphene quantum dots (GQDs) were conjectured to produce new or improve current methods used for bioimaging, drug delivery …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schroeder et al. | Graphene Quantum Dots for Theranostics and Bioimaging: KL Schroeder et al. | |
| Wang et al. | Multifunctional carbon dots for biomedical applications: diagnosis, therapy, and theranostic | |
| Pechnikova et al. | Carbon quantum dots in biomedical applications: advances, challenges, and future prospects | |
| Azam et al. | Carbon quantum dots for biomedical applications: review and analysis | |
| Mauro et al. | Functionalization of metal and carbon nanoparticles with potential in cancer theranostics | |
| Gao et al. | Fluorine-doped carbon dots with intrinsic nucleus-targeting ability for drug and dye delivery | |
| Zhang et al. | Cell membrane-coated porphyrin metal–organic frameworks for cancer cell targeting and O2-evolving photodynamic therapy | |
| Dong et al. | Application of graphene quantum dots for simultaneous fluorescence imaging and tumor-targeted drug delivery | |
| Pelaz et al. | Diverse applications of nanomedicine | |
| Zhang et al. | Mitochondria-targeting nanoplatform with fluorescent carbon dots for long time imaging and magnetic field-enhanced cellular uptake | |
| Feng et al. | New horizons for diagnostics and therapeutic applications of graphene and graphene oxide | |
| Mazrad et al. | Progress in internal/external stimuli responsive fluorescent carbon nanoparticles for theranostic and sensing applications | |
| Yang et al. | Nano-graphene in biomedicine: theranostic applications | |
| Lai et al. | Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release | |
| Qu et al. | Recent advance of carbon dots in bio-related applications | |
| Dubey et al. | Review of carbon dot-based drug conjugates for cancer therapy | |
| Yang et al. | In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice | |
| Xu et al. | Dual-targeting nanosystem for enhancing photodynamic therapy efficiency | |
| Sharker et al. | Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging | |
| Zhang et al. | Magnetofluorescent carbon quantum dot decorated multiwalled carbon nanotubes for dual-modal targeted imaging in chemo-photothermal synergistic therapy | |
| Kailasa et al. | Carbon dots as carriers for the development of controlled drug and gene delivery systems | |
| Liang et al. | Ph and thermal dual-responsive graphene oxide nanocomplexes for targeted drug delivery and photothermal-chemo/photodynamic synergetic therapy | |
| Wang et al. | Preparation of novel fluorescent nanocomposites based on Au nanoclusters and their application in targeted detection of cancer cells | |
| Sharma et al. | Comprehensive review on fluorescent carbon dots and their applications in nucleic acid detection, nucleolus targeted imaging and gene delivery | |
| Warjurkar et al. | Red emissive carbon dots: a promising next-generation material with intracellular applicability |